![Maciej M Mrugala: Updates in advanced urothelial carcinoma at the Mayo Clinic and University of Athens meeting](https://oncodaily.com/pub/uploads/2024/01/Petros-Grivas-e1724611822592.png)
Maciej M Mrugala: Updates in advanced urothelial carcinoma at the Mayo Clinic and University of Athens meeting
Petros Grivas shared a post by Maciej M Mrugala, Director-Neuro-Oncology Fellowship Program at Mayo Clinic on X, adding:
“Thanks Maciej M Mrugala so kind of you!
Such a great pleasure to present the revolution in bladder cancer in my home town, see friends and colleagues and celebrate together my Name day.”
Quoting Maciej M Mrugala’s post:
“Petros Grivas from University of Washington, Fred Hutchinson Cancer Center delivering great talk on progress in urothelial cancer at the Mayo Clinic and University of Athens meeting – as it happens – and per Greek tradition – he is celebrating his name day today!
Happy Name Day Petros!”
Source: Petros Grivas/X and Maciej M Mrugala/X
Dr. Petros Grivas, a board-certified medical oncologist, serves as Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance.
He’s an Associate Professor at the Dept. of Medicine and Associate Member at Fred Hutchinson Cancer Research Center since January 2018. With extensive training and experience, he’s led clinical trials, contributing to FDA approvals for bladder/urothelial cancer treatments.